The first of nearly four dozen new built-to-rent homes were unveiled in Arlington's Viridian community on July 15, offering ...

Independant watchmaker, Czapek has partnered with Fratello once again for an exclusive timepiece collaboration, starring the Promenade Transparencies “Viridian Green.” Marking the duo’s ...

Located within a 2,000-acre master-planned community, the luxury project will have a mix of apartments and townhomes.

Viridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage study, sending its shares ...

StreetLights Residential has broken ground on the third and final phase of its multifamily development in Arlington’s ...

Viridian Therapeutics has a couple of milestones upcoming in 2025 and more pivotal once scheduled in 2026. Click here to find out why VRDN stock is a Buy.

poem about the word Greenan exploration of the viridian-hued button-up slung across my shoulders, or to put it more concisely, Green ...

A medallion made with the sap of the Erdtree, the Viridian Amber Medallion raises its user’s maximum stamina. This medallion has many green ambers inlaid, which represent the primordial life ...

Viridian's thyroid eye disease drug veligrotug clears its first phase 3 trial, with data suggesting it could be competitive with Amgen's Tepezza.

Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become the first ...

Viridian Therapeutics (VRDN) stock gains as company announces positive Phase 3 trial results for veligrotug in active thyroid eye disease. Read more here.